Some of the reasons more producers are looking at antibiotic-free (ABF) meat include strong demand from consumers, restaurants and other food service companies; the threat of antimicrobial resistance; and stringent regulations on the use of antibiotics. There are many other good reasons for poultry producers to strive for ABF production systems, including to successfully produce poultry meat without antibiotics. This requires a paradigm shift starting at the parent stock level, with ABF production of hatching eggs. The poultry industry needs find a
This webinar will broadcast at 7:00 AM CST (Chicago) / 1:00 PM GMT (London) / 9:00 PM CST (Beijing).
WHAT YOU’LL LEARN:
- How the cornerstones of the antibiotic reduction program have delivered dramatic results for the poultry industry. These include replacing where possible, reducing overall use and refining best practice.
- How in recent years, reducing the use of antibiotics in animal production has become a top priority, due to concerns about the development of antibiotic-resistant bacteria and mounting consumer pressure. Multiple countries have introduced bans or severe restrictions on the non-therapeutic use of antibiotics, including in the US, where the Food and Drug Administration has implemented measures to curb the use of antibiotics since 2017.
- How the top priority of farmers and chicken companies to raise healthy chickens is directly related to a safe food supply. There also are responsible, approved standards of veterinary treatment that benefit animal welfare and human health.
- How to work with animal and human health experts to develop a methodology for rapid on-farm diagnostics to ensure early diagnosis. The aim is to use the diagnostic and sensitivity testing tools to better map bird health and welfare, evaluate the impact of disease control programs and implement robust surveillance.
This webinar is proudly sponsored by Boehringer Ingelheim and presented by WATTPoultry and WATT Global Media.
Speaker Info:
Dr. Jeanine Wiegel, DVM MAHM Poultry veterinarian, GD Animal Health
Dr. Stephane Lemiere, global head at Boehringer Ingelheim